<VariationArchive VariationID="423471" VariationName="NM_005670.4(EPM2A):c.466_469dup (p.Tyr157fs)" VariationType="Duplication" Accession="VCV000423471" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="406824" VariationID="423471">
      <GeneList>
        <Gene Symbol="EPM2A" FullName="EPM2A glucan phosphatase, laforin" GeneID="7957" HGNC_ID="HGNC:3413" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145383353" stop="145736023" display_start="145383353" display_stop="145736023" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="145946439" stop="146056990" display_start="145946439" display_stop="146056990" Strand="-" />
          </Location>
          <OMIM>607566</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005670.4(EPM2A):c.466_469dup (p.Tyr157fs)</Name>
      <CanonicalSPDI>NC_000006.12:145686128:AATG:AATGAATG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145686128" stop="145686129" display_start="145686128" display_stop="145686129" variantLength="4" positionVCF="145686128" referenceAlleleVCF="T" alternateAlleleVCF="TAATG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="146007264" stop="146007265" display_start="146007264" display_stop="146007265" variantLength="4" positionVCF="146007264" referenceAlleleVCF="T" alternateAlleleVCF="TAATG" />
      </Location>
      <ProteinChange>Y157fs</ProteinChange>
      <ProteinChange>Y19fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012832.2" sequenceAccession="NG_012832" sequenceVersion="2" change="g.54724_54727dup">
            <Expression>NG_012832.2:g.54724_54727dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018041.2" sequenceAccession="NM_001018041" sequenceVersion="2" change="c.466_469dup">
            <Expression>NM_001018041.2:c.466_469dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018051.1" sequenceAccession="NP_001018051" sequenceVersion="1" change="p.Tyr157fs">
            <Expression>NP_001018051.1:p.Tyr157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360057.2" sequenceAccession="NM_001360057" sequenceVersion="2" change="c.466_469dup">
            <Expression>NM_001360057.2:c.466_469dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001346986.1" sequenceAccession="NP_001346986" sequenceVersion="1" change="p.Tyr157fs">
            <Expression>NP_001346986.1:p.Tyr157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.146007265_146007268dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.146007265_146007268dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.145686129_145686132dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.145686129_145686132dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360064.2" sequenceAccession="NM_001360064" sequenceVersion="2" change="c.52_55dup">
            <Expression>NM_001360064.2:c.52_55dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001346993.1" sequenceAccession="NP_001346993" sequenceVersion="1" change="p.Tyr19fs">
            <Expression>NP_001346993.1:p.Tyr19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368131.1" sequenceAccession="NM_001368131" sequenceVersion="1" change="c.52_55dup">
            <Expression>NM_001368131.1:c.52_55dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355060.1" sequenceAccession="NP_001355060" sequenceVersion="1" change="p.Tyr19fs">
            <Expression>NP_001355060.1:p.Tyr19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368132.1" sequenceAccession="NM_001368132" sequenceVersion="1" change="c.-158_-155dup">
            <Expression>NM_001368132.1:c.-158_-155dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005670.4" sequenceAccession="NM_005670" sequenceVersion="4" change="c.466_469dup" MANESelect="true">
            <Expression>NM_005670.4:c.466_469dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005661.1" sequenceAccession="NP_005661" sequenceVersion="1" change="p.Tyr157fs">
            <Expression>NP_005661.1:p.Tyr157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_153398.2" sequenceAccession="NR_153398" sequenceVersion="2" change="n.281_284dup">
            <Expression>NR_153398.2:n.281_284dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360071.2" sequenceAccession="NM_001360071" sequenceVersion="2" change="c.52_55dup">
            <Expression>NM_001360071.2:c.52_55dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001347000.1" sequenceAccession="NP_001347000" sequenceVersion="1" change="p.Tyr19fs">
            <Expression>NP_001347000.1:p.Tyr19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368129.2" sequenceAccession="NM_001368129" sequenceVersion="2" change="c.-158_-155dup">
            <Expression>NM_001368129.2:c.-158_-155dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368130.1" sequenceAccession="NM_001368130" sequenceVersion="1" change="c.466_469dup">
            <Expression>NM_001368130.1:c.466_469dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355059.1" sequenceAccession="NP_001355059" sequenceVersion="1" change="p.Tyr157fs">
            <Expression>NP_001355059.1:p.Tyr157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16618250" DB="ClinGen" />
        <XRef Type="rs" ID="1554263320" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005670.4(EPM2A):c.466_469dup (p.Tyr157fs) AND not provided" Accession="RCV000483237" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-02-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005670.4(EPM2A):c.466_469dup (p.Tyr157fs) AND Progressive myoclonic epilepsy" Accession="RCV003746527" Version="1">
        <ClassifiedConditionList TraitSetID="13597">
          <ClassifiedCondition DB="MedGen" ID="C0751778">Progressive myoclonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20738377</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13597" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3141" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Progressive myoclonic epilepsy</ElementValue>
                <XRef ID="Progressive+myoclonic+epilepsy/9622" DB="Genetic Alliance" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial progressive myoclonic epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic Epilepsies, Progressive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonus epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progressive myoclonus epilepsy</ElementValue>
                <XRef ID="MONDO:0020074" DB="MONDO" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7140" />
                <XRef ID="7140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng217</URL>
                <CitationText>UK NICE Guideline NG217, Epilepsies in children, young people and adults, 2022</CitationText>
              </Citation>
              <XRef ID="308" DB="Orphanet" />
              <XRef ID="98261" DB="Orphanet" />
              <XRef ID="C0751778" DB="MedGen" />
              <XRef ID="MONDO:0020074" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS254800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1108281" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:1481498|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000573174" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.466_469dupCATT variant in the EPM2A gene causes a frameshift starting with codon Tyrosine 157, changes this amino acid to a Serine residue and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Y157SfsX13. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense mediated mRNA decay. The c.466_469dupCATT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server. Therefore, we interpret c.466_469dupCATT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPM2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="AATGAATG" referenceAllele="AATG" start="146007264" stop="146007265" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005670.3:c.466_469dupCATT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8261102" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="15004112|MedGen:C0751778" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004471660" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20738377</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 423471). This variant has not been reported in the literature in individuals affected with EPM2A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr157Serfs*13) in the EPM2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EPM2A are known to be pathogenic (PMID: 20738377).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPM2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.146007264_146007265insAATG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751778" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1108281" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8261102" TraitType="Disease" MappingType="XRef" MappingValue="C0751778" MappingRef="MedGen">
        <MedGen CUI="C0751778" Name="Progressive myoclonic epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

